Health & Wellness Today New York: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health & Wellness Today New York.

Press releases published on September 30, 2026

MENTAL HEALTH MATTERS: BLANTON-PEALE INSTITUTE HOSTS MENTAL HEALTH AWARENESS EVENTS ACROSS NEW YORK CITY
Amy Silva-Magalhaes of The Bristal Assisted Living Named to Long Island Business News’ 2026 Healthcare Influencers List
Sick Child, School Note, Missed Work: New DrHouse Data Reveals the Hidden Burden of School Sick Days
World Parkinson Coalition Announces Five New Members to Board of Directors
Brookbush Institute Publishes: 'Cost Comparison of Personal Trainer Certifications (2026), Including the Hidden Fees'
VAI Launches AI Assistant to Deliver Instant ERP Business Intelligence
Everyone Matters President Recently Selected for Top 25 Global Impact Leaders By IAOTP
Resurge Selected as Top Business of the Year by the International Association of Top Businesses (IAOTB)
Adial Pharmaceuticals Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Oculis Announces Resignation of Lionel Carnot from Board of Directors
Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference
Immix Biopharma Announces Closing of $125 Million Underwritten Offering of Common Stock
Standard BioTools Provides Update on Sale of Mass Cytometry Business
TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitiveness
Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements
Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer
Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026
Longeveron to Participate in Three Longevity/Aging Investment Conferences
Atsena Presents Positive 18-Month Results from Part A of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Health & Wellness Today New York

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.